ARTICLE | Clinical News
XaraColl regulatory update
November 14, 2016 9:47 PM UTC
Innocoll submitted an NDA to FDA for XaraColl bupivacaine collagen-matrix implants to treat postsurgical pain. The NDA is based on data from the Phase III MATRIX-1 and MATRIX-2 trials (see BioCentury,...
BCIQ Company Profiles